DSM Integrated Annual Report 2022

16 Equity

 

 

2022

 

2021

 

 

 

 

 

Balance at 1 January

 

9,397

 

7,487

 

 

 

 

 

Net profit for the year

 

1,715

 

1,680

Other comprehensive income

 

227

 

643

Options/share units granted

 

34

 

22

Dividend

 

(459)

 

(424)

Proceeds from reissue of ordinary shares

 

141

 

193

Acquisition of NCI without a change in control

 

-

 

(13)

Acquisition (divestment) of subsidiary with NCI

 

(4)

 

(24)

Repurchase of shares

 

(210)

 

(165)

Other changes

 

4

 

(2)

Balance at 31 December

 

10,845

 

9,397

Dividend

For the year 2022, the following dividends were proposed by the Managing Board.

 

 

2022

 

2021

 

 

 

 

 

Per cumulative preference share A: €0.13 (2021: €0.13)

 

6

 

6

Per ordinary share: €0.93 (2021: €2.50)

 

161

 

432

Total

 

167

 

438

The proposed final dividend on ordinary shares is subject to approval by the Annual General Meeting of Shareholders. See also the paragraph on Profit appropriation in Note 6 Shareholders’ equity  to the Parent company financial statements.

For a description of the rules of profit appropriation and of the statutory rights attached to Cumulative Preference Shares A and B, see Note 6 Shareholders’ equity to the Parent company financial statements.

Share capital

On 31 December 2022, the authorized capital amounted to €1,125 million (2021: €1,125 million), distributed over 330,960,000 ordinary shares, 44,040,000 Cumulative Preference Shares A and 375,000,000 Cumulative Preference Shares B. All shares have a nominal value of €1.50 each. The outstanding shares provide an entitlement of one vote per share at the General Meeting of Shareholders. All rights attached to the Company’s shares held by the Group (treasury shares) are suspended until those shares are reissued.

Every year the Managing Board, with the approval of the Supervisory Board, shall decide which part of the profit shall be set aside. Out of the profit remaining, a dividend based on EURIBOR, plus a premium at the company’s discretion, shall be distributed insofar as possible on the Cumulative Preference Shares B. From the amount remaining of the profit, a dividend shall be distributed insofar as possible on the Cumulative Preference Shares A, the percentage based on the effective return on government loans, increased by a mark-up to be determined at the company’s discretion. If, for any financial year, the distributions on the Cumulative Preference Shares B and A cannot be effected or cannot be fully effected because the profit after reservation does not suffice, the deficit shall be distributed to the debit of the following financial years. In that case, each time as much as possible, the overdue dividend, augmented by the dividend for the last expired financial year, shall be distributed, first on Cumulative Preference Shares B and next on Cumulative Preference Shares A. The remaining profit shall be put at the disposal of the General Meeting of Shareholders.

The changes in the number of issued and outstanding shares in 2021 and 2022 are shown in the following table.

Overview of shares

 

 

Issued shares

 

Issued shares

 

Treasury shares

 

 

Ordinary

 

Cumprefs A

 

Ordinary

 

 

 

 

 

 

 

Balance at 1 January 2021

 

181,425,000

 

44,040,000

 

9,205,661

 

 

 

 

 

 

 

Cancellation of issued shares

 

(6,638,971)

 

 

 

(6,638,971)

Reissue of shares in connection with share-based payments

 

 

 

 

 

(803,049)

Repurchase of shares

 

 

 

 

 

1,050,000

Bearer share certificates that have become void

 

 

 

 

 

7,466

Dividend in the form of ordinary shares

 

 

 

 

 

(1,003,808)

Balance at 31 December 2021

 

174,786,029

 

44,040,000

 

1,817,299

 

 

 

 

 

 

 

Number of treasury shares at 31 December 2021

 

(1,817,299)

 

 

 

 

Number of shares outstanding at 31 December 2021

 

172,968,730

 

44,040,000

 

 

 

 

 

 

 

 

 

Balance at 1 January 2022

 

174,786,029

 

44,040,000

 

1,817,299

 

 

 

 

 

 

 

Reissue of shares in connection with share-based payments

 

 

 

 

 

(617,967)

Repurchase of shares

 

 

 

 

 

1,330,000

Dividend in the form of ordinary shares

 

 

 

 

 

(818,700)

Balance at 31 December 2022

 

174,786,029

 

44,040,000

 

1,710,632

 

 

 

 

 

 

 

Number of treasury shares at 31 December 2022

 

(1,710,632)

 

 

 

 

Number of shares outstanding at 31 December 2022

 

173,075,397

 

44,040,000

 

 

The average number of ordinary shares outstanding in 2022 was 172,826,732 (2021: 172,647,995). All shares issued are fully paid.

The Cumulative Preference Shares A have been classified as equity, because there is no mandatory redemption and distributions to the shareholders are at the discretion of DSM. On 31 December 2022, no Cumulative Preference Shares B were outstanding (same as 2021).

Share premium

Of the total share premium of €471 million (2021: €471 million), an amount of €87 million (2021: €89 million) can be regarded as entirely free of tax.

Treasury shares

In 2022, DSM repurchased 0.7 million shares for an amount of €116 million to cover commitments for stock dividend, and 0.6 million shares for an amount of €95 million to fulfill its obligations under share-based compensation plans.

At 31 December 2022, DSM possessed 1,710,632 (2021: 1,817,299) ordinary shares with a nominal value of €3 million, or 0.78% (2021: 0.83%) of the share capital. The average purchase price of the ordinary treasury shares as at 31 December 2022 was €114.81 (2021: €97.50). At 31 December 2022, 1,647,106 (2021: 1,665,073) of the total number of treasury shares outstanding were held for servicing share-option rights and share plans and 63,526 (2021: 152,226) shares for stock dividend.

Other reserves in Shareholders’ equity

 

 

Translation reserve

 

Hedging reserve

 

Reserve for share-based compensation

 

Fair value reserve

 

Total

 

 

 

 

 

 

 

 

 

 

 

Balance at 1 January 2021

 

(289)

 

(68)

 

41

 

73

 

(243)

 

 

 

 

 

 

 

 

 

 

 

Changes:

 

 

 

 

 

 

 

 

 

 

Fair-value changes of derivatives

 

-

 

(24)

 

-

 

-

 

(24)

Release to income statement

 

(13)

 

7

 

-

 

-

 

(6)

Fair-value changes of other financial assets

 

-

 

-

 

-

 

46

 

46

Exchange differences

 

478

 

-

 

-

 

-

 

478

Options and performance shares granted

 

-

 

-

 

22

 

-

 

22

Options and performance shares exercised/canceled

 

-

 

-

 

(24)

 

-

 

(24)

Transfer to retained earnings

 

-

 

-

 

-

 

(101)

 

(101)

Changes in joint ventures and associates

 

1

 

-

 

-

 

-

 

1

Income tax

 

-

 

8

 

-

 

(1)

 

7

Total changes

 

466

 

(9)

 

(2)

 

(56)

 

399

 

 

 

 

 

 

 

 

 

 

 

Balance at 31 December 2021

 

177

 

(77)

 

39

 

17

 

156

 

 

 

 

 

 

 

 

 

 

 

Changes:

 

 

 

 

 

 

 

 

 

 

Fair-value changes of derivatives

 

-

 

(6)

 

-

 

-

 

(6)

Release to income statement

 

(16)

 

53

 

-

 

-

 

37

Fair-value changes of other financial assets

 

-

 

-

 

-

 

(61)

 

(61)

Exchange differences

 

267

 

-

 

-

 

-

 

267

Options and performance shares granted

 

-

 

-

 

34

 

-

 

34

Options and performance shares exercised/canceled

 

-

 

-

 

(29)

 

-

 

(29)

Transfer to retained earnings

 

-

 

-

 

-

 

(28)

 

(28)

Income tax

 

(4)

 

(3)

 

-

 

-

 

(7)

Total changes

 

247

 

44

 

5

 

(89)

 

207

 

 

 

 

 

 

 

 

 

 

 

Balance at 31 December 2022

 

424

 

(33)

 

44

 

(72)

 

363

The increase in the Translation reserve in 2022 is mainly caused by a weakening of the euro against the US dollar, Swiss franc and Brazilian real versus a strengthening against the Chinese renminbi. As a consequence, the total value of the subsidiaries increased, which led to a positive exchange difference of €267 million.

The Translation reserve, Hedging reserve and Fair value reserve (partly) are legal reserves in accordance with Dutch law and cannot be distributed to shareholders. Additional information is provided in Note 6 Shareholders’ equity to the Parent company financial statements.